Trump’s Shock and Awe Campaign Is Our Conservative Dream Come True
Here Are the Final Details Between Colombia and the US Over Deportation Flights
If It Wasn't on HBO, ESPN's Stephen A. Smith Wouldn't Be Invited Back...
Hear, See, Speak No Evil!
Demoralized Democrats Are Dazed and Confused
Trump’s Opportunity in the Greater Middle East
WH Hails Capturing Top Illegal Immigrant Criminals and It's Monumental
How RFK Jr. Plans to Tackle the Opioid Crisis
Trump Releases Weapons Biden Withheld From Israel
NYC Sees First Five-Day Period in 30 Years With No Shooting Victims
Federal Worker Slams Trump’s Executive Order: 'It’s Making My Job Harder'
How JD Vance Was the Man Behind the J6 Pardons
JD Vance's First Interview as VP Is Brilliant
UPDATE: Colombia President Backs Down After Trump Threatens Nation for Rejecting Deportati...
Under Trump’s 'One Flag Policy,' Only Old Glory Takes the Spotlight
Tipsheet

We're Already Seeing the Effects of Trump Nominating RFK Jr. to HHS

AP Photo/Ross D. Franklin

Vaccine stocks are continuing to fall after President-elect Donald Trump announced he would nominate Robert F. Kennedy Jr. to lead the Department of Health and Human Services. 

Advertisement

“We have a generational opportunity to bring together the greatest minds in science, medicine, industry, and government to put an end to the chronic disease epidemic,” Kennedy said in a statement Thursday after Trump nominated him.  

At 1204 GMT, shares in Britain's GSK (GSK.L), opens new tab were down 3.2% at their lowest in more than a year, while AstraZeneca and France's Sanofi (SASY.PA), opens new tab were down between 2.6% and 2.8% respectively. [...]

Sartorius (SATG.DE), opens new tab, a major supplier of biotech lab gear and substances, fell 3.8%.

Bavarian Nordic (BAVA.CO), opens new tab, which makes a vaccine for mpox, was down 16%, also hurt by third-quarter results

The Danish biotech firm's CEO voiced concerns that RFK Jr, as he is known, could fuel vaccine scepticism but also told Reuters that the U.S. response to the COVID-19 pandemic during Trump's first term made him confident about future bio-defence funding by the incoming U.S. administration.

German-listed shares of BioNtech (22UAy.DE), opens new tab, Pfizer's partner on COVID-19 vaccines, were down more than 10%, set for their biggest one-day fall since August.  [...]

In premarket trading, U.S. vaccine makers fell further after Thursday's declines, with Moderna (MRNA.O), opens new tab down 2.21% after hitting its lowest since April 2020 on Thursday and Novavax (NVAX.O), opens new tab 1.94% lower. 

Pfizer (PFE.N), opens new tab was marginally lower after falling to April lows a day earlier. (Reuters

Advertisement

"For too long, Americans have been crushed by the industrial food complex and drug companies who have engaged in deception, misinformation, and disinformation when it comes to Public Health," Trump said in a statement announcing Kennedy as his pick to lead HHS. "The Safety and Health of all Americans is the most important role of any Administration, and HHS will play a big role in helping ensure that everybody will be protected from harmful chemicals, pollutants, pesticides, pharmaceutical products, and food additives that have contributed to the overwhelming Health Crisis in this Country. Mr. Kennedy will restore these Agencies to the traditions of Gold Standard Scientific Research, and beacons of Transparency, to end the Chronic Disease epidemic, and to Make America Great and Healthy Again!"

Advertisement

Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos

Advertisement
Advertisement
Advertisement